KevzaraŽ (sarilumab) Data at the 2018 ACR/ARHP Annual Meeting Provide Additional Insight on Safety and Efficacy in Rheumatoid Arthritis

Friday, October 19, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Among 13 Alliance presentations, a late-breaker poster will highlight potential for IL-6 levels to serve as a biomarker to help predict treatment response

Regeneron Contacts:

Sanofi Contacts:

Media Relations

Media Relations

Sarah Cornhill

Ashleigh Koss

Tel: +1 (914) 847-5018

Tel: +1 (908) 981-8745

Sarah.Cornhill@regeneron.com

ashleigh.koss@sanofi.com

Investor Relations

Investor Relations

Manisha Narasimhan, Ph.D.

George Grofik

Tel: +1 (914) 847-5126

Tel: +33 (0)1 53 77 45 45

manisha.narasimhan@regeneron.com

ir@sanofi.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store